UpdatesPress Release
Epigral reported record Q4FY26 revenue of ₹736 Cr, up 17% YoY, with PAT jumping 109% QoQ and EBITDA margins at 23%. A ₹5 per share dividend is proposed.
Epigral LimitedEPIGRAL · Filed with the exchange
Major CPVC and Epichlorohydrin capacity expansions are on track, targeting future growth.
No comments yet. Be the first.